Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02104622 · ClinicalTrials.gov registry record · NA

Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

A NA study of Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02104622: Completed NA study of Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab.

NCT02104622 is a NA study of Spinal Cord Injury that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 10 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02104622, a NA study of Spinal Cord Injury, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Many people with spinal cord injury are no longer able to walk and must use wheelchairs for mobility. These individuals experience greater rates of depression and lower quality of life. Many of these individuals express a strong desire to walk again, and report many psychosocial benefits to being eye to eye with peers in social interactions. Additionally, wheelchairs allow only limited community access, creating an additional obstacle to seeking out meaningful social roles in the community. Currently, there is new technology called robotic exoskeletons that would allow people with spinal cord injury to walk. These robotic exoskeletons also allow for curb, ramp, and stair negotiation, which are critical to community access. Current research has examined training with robotic exoskeletons indoors over level surfaces in clinical settings. This study will examine the potential for everyday use, including ramps, stairs, curbs and indoor and outdoor use.

Primary Outcome

The goal is to cover as much ground as possible over 6 minutes, the distance is measured with a measuring wheel. The instructions are "Walk continuously if possible, but do not be concerned if you need to slow down or stop to rest." At the end of 6 minutes the participant is asked to rate their exertion level on a Borg Scale of 6 - 20 points. The VO2 MAX data is collected during the test every 10 seconds

Conditions Studied

Interventions

  • DEVICE ReWalk Rehabilitation 2.0

Study Locations (1)

Illinois

  • Rehabilitation Institute of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-02
Est. Completion 2020-01
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the finished NCT02104622 record still lists

NCT02104622 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which ReWalk Rehabilitation 2.0 is the first listed.

NCT02104622 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02104622 about?

NCT02104622 is a clinical study titled "Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation". Many people with spinal cord injury are no longer able to walk and must use wheelchairs for mobility. These individuals experience greater rates of depression and lower quality of life. Many of these individuals express a strong desire to walk again, and report many psychosocial benefits to being ey...

What is the current status of trial NCT02104622?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-02. Estimated completion is 2020-01.

What conditions does trial NCT02104622 study?

This clinical trial studies the following conditions: Spinal Cord Injury.

What interventions are being tested in trial NCT02104622?

The interventions under investigation include: ReWalk Rehabilitation 2.0 (DEVICE).

Who is sponsoring clinical trial NCT02104622?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02104622 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02104622's enrollment target sits among peer trials

10 82nd of 99 higher than 8 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01870752 · 10 participants · NA

    Ovarian Tissue Transplantation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02104622, the US trial registry maintained by the National Library of Medicine. NCT02104622 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.